Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Bionik Laboratories Corp (BNKL)
OTHER OTC:BNKL
Holding BNKL?
Track your performance easily
BNKL Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.10 - $0.10
Previous Close$0.1
Volume123.00
Average Volume (3M)N/A
Market Cap
$1.25K
Enterprise Value$2.01M
Total Cash (Recent Filing)$400.00K
Total Debt (Recent Filing)$2.41M
Price to Earnings (P/E)―
Beta32.59
Next Earnings
Feb 14, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding12,480,000
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard Deviation0.55
R-Squared0.03
Alpha0.03
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)1.33
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.12
Enterprise Value/Gross Profit2.03
Enterprise Value/Ebitda-0.58
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
BNKL FAQ
What was Bionik Laboratories Corp’s price range in the past 12 months?
Bionik Laboratories Corp lowest stock price was $0.10 and its highest was $0.10 in the past 12 months.
What is Bionik Laboratories Corp’s market cap?
Currently, no data Available
When is Bionik Laboratories Corp’s upcoming earnings report date?
Bionik Laboratories Corp’s upcoming earnings report date is Feb 14, 2024 which is 286 days ago.
How were Bionik Laboratories Corp’s earnings last quarter?
Currently, no data Available
Is Bionik Laboratories Corp overvalued?
According to Wall Street analysts Bionik Laboratories Corp’s price is currently Overvalued.
Does Bionik Laboratories Corp pay dividends?
Bionik Laboratories Corp does not currently pay dividends.
What is Bionik Laboratories Corp’s EPS estimate?
Bionik Laboratories Corp’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Bionik Laboratories Corp have?
Bionik Laboratories Corp has 12,480,263 shares outstanding.
What happened to Bionik Laboratories Corp’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Bionik Laboratories Corp?
Currently, no hedge funds are holding shares in BNKL
---
Company Description
Bionik Laboratories Corp
Bionik Laboratories Corp. engages in the provision of rehabilitation and mobility solutions to individuals with neurological disorders. Its products include InMotion ARM, InMotion HAND, and InMotion WRIST. The company was founded by Michal Prywata and Thiago Caires on January 8, 2010 and is headquartered in Toronto, Canada.
---
---